All articles by Andrew Turley – Page 8
-
Business
Takeda buys into Brazil for 540m reals
Multilab makes generics and over-the-counter branded products
-
Business
Solvay opens 200 employee Indian R&D centre
Belgian chemical company opens centre in Savli, Gujarat State
-
News
Half of sun products have BASF UV filters
Company says that 50% of all 'sun care' products sold today contain its organic UV-A filters
-
Business
Dow partners with Oz university
Dow is to partner with the University of Queensland in Australia
-
Business
Seroquel patent row continues
The legal tug of war over the right to sell generic versions of Seroquel (quetiapine) tablets continues
-
Business
Half of sun products have BASF UV filters
German chemical giant BASF says that 50% of all ‘sun care’ products sold today contain its organic UV-A filters
-
Business
US approves new anaemia drug
US authorities have approved Omontys (peginesatide) injections for treating anaemia in dialysis patients with chronic kidney disease
-
Business
Light materials from Bayer
Bayer has launched a lightweight material designed to replace steel in railway locomotive and carriage construction
-
Business
PCSK9 inhibitors against cholesterol problems perform well
Sanofi has reported Phase II data for a new drug candidate for lowering cholesterol levels in patients already taking statins
-
Business
$500m for Ista
US eye drug company Bausch & Lomb has signed a cash deal to buy US drugmaker Ista Pharmaceuticals for $9.10 per share, equivalent to $500 million
-
Business
EPA proposes new rules for five chemicals
The US Environmental Protection Agency has proposed new rules that would force companies to report any new use
-
Business
AbbVie emerges from Abbott split
US healthcare giant Abbott has renamed the branded drugs part of its business
-
News
GSK to build £350 million factory in UK
Tax breaks in the UK budget have prompted GSK to reaffirm its commitment
-
Business
GSK to build £350m factory in UK
GlaxoSmithKline (GSK) has announced £350 million plans to build its first new UK production plant for almost 40 years in Ulverston, Cumbria
-
News
GSK to build £350 million factory in UK
Tax breaks in the UK budget have prompted GSK to reaffirm its commitment
-
Careers
Chew's life
Revolymer’s expertise in polymer chemistry has brought non-stick, biodegradable chewing gum to the mass market
-
News
AstraZeneca to cut 7300 more jobs
The cost cutting trend is set to continue as big pharma reels from patent expiries
-
News
BMS spends $2.5 billion on antiviral firm
Inhibitex acquisition is one of several recent moves in the hepatitis C market
-
News
EU probes Honeywell and DuPont over green
Complaints from companies looking to manufacture 1234yf have led to a formal investigation into anticompetitive behaviour